Recall record at a glance
| Official record | F-0803-2024 |
|---|---|
| Category | Food Recalls |
| Classification | Class III |
| FDA record status | Terminated |
| Recalling firm | Nestle Product Technology Center - Nestle Health Science |
| Report date | Feb 7, 2024 |
| Recall initiation date | Dec 22, 2023 |
| Quantity | 612 bottles |
| Location | Bridgewater, NJ, United States |
Official product description
Solgar, Triple Strength, Shellfish -Free, Glucosamine Chondroitin MSM, 120 Tablets per bottle. Glass Bottle, 12 per Case, Store at room temperature . Product Number -1319
Why the product was recalled
Nestle Health Science has initiated a recall of Solgar Glucosamine Chondroitin, 120 Tablets, in Glass bottle, 12 bottles per case because of error during packaging in which a A Megasorb B-Complex product was filled into bottles labeled as Glucosamine_Chondroitin MSM.
Distribution information
The recalled product was distributed to the following states: NY, IN, PA, TX, TN, NV
How to read the classification
FDA Class III generally covers situations in which use of or exposure to the product is not likely to cause adverse health consequences. The classification displayed here is taken from the FDA enforcement record.
Additional record details
Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.
What to do next
If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.
About this record
Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.
FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.